Pro Medicus Ltd
F:PMC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Pro Medicus Ltd (PMC) under the Base Case is 13.52 EUR per share.
Compared with the current market price of 122.08 EUR, the stock appears
Overvalued by 89% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Pro Medicus Does
Pro Medicus makes medical imaging software for hospitals, radiology groups, and other healthcare providers. Its main product is Visage, a system that helps doctors store, view, share, and interpret scans such as X-rays, CTs, and MRIs on fast digital workstations and cloud-based setups. The company does not sell medical devices or run clinics; it sells software that sits in the workflow between imaging equipment and the clinicians who read the images.
- Headquarters
- Australia AU
- Employees
- 132
- IPO date
- Oct 10, 2000
Pro Medicus has a wide economic moat
Patented image-streaming technology lets hospitals view medical scans quickly while using less hardware than many competing systems. Once Pro Medicus software is connected to a hospital’s image archives and clinical workflows, moving to another provider can require substantial data transfer and rebuilding work.
Read the full moat analysis
Earnings Waterfall
Pro Medicus Ltd
What is the Intrinsic Value of one PMC stock?
The intrinsic value for Pro Medicus Ltd (PMC) under the Base Case is 13.52 EUR.
Is PMC stock undervalued or overvalued?
Compared with the current market price of 122.08 EUR, the stock appears Overvalued by 89% .
